bupropion has been researched along with Cognition Disorders in 8 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to examine the effects of tobacco abstinence and bupropion treatment on cognitive functioning in adult smokers with schizophrenia in the setting of a randomized, double-blind, placebo-controlled clinical trial of bupropion for smoking cessation." | 9.11 | Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. ( Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA, 2005) |
| "The objective of this study was to examine the effects of tobacco abstinence and bupropion treatment on cognitive functioning in adult smokers with schizophrenia in the setting of a randomized, double-blind, placebo-controlled clinical trial of bupropion for smoking cessation." | 5.11 | Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia. ( Cather, C; Culhane, MA; Deckersbach, T; Evins, AE; Freudenreich, O; Goff, DC; Green, MF; Henderson, DC; Rigotti, NA; Schoenfeld, DA, 2005) |
| "Reduced suicidal ideation was best predicted by a combination of the independent improvements in both depression symptomatology and verbal memory." | 2.80 | Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion. ( Burke, A; Gorlyn, M; Grunebaum, M; Keilp, J; Mann, JJ; Oquendo, M, 2015) |
| "Major depression and dysthymia are common and often disabling disorders in late life." | 1.30 | Diagnosis and treatment of depression in late life. ( Downs, NS; Zisook, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Perkins, KA | 1 |
| Karelitz, JL | 1 |
| Jao, NC | 1 |
| Gur, RC | 1 |
| Lerman, C | 1 |
| Freeman, MP | 1 |
| Gorlyn, M | 1 |
| Keilp, J | 1 |
| Burke, A | 1 |
| Oquendo, M | 1 |
| Mann, JJ | 1 |
| Grunebaum, M | 1 |
| Evins, AE | 1 |
| Deckersbach, T | 1 |
| Cather, C | 1 |
| Freudenreich, O | 1 |
| Culhane, MA | 1 |
| Henderson, DC | 1 |
| Green, MF | 1 |
| Schoenfeld, DA | 1 |
| Rigotti, NA | 1 |
| Goff, DC | 1 |
| Ling, W | 2 |
| Rawson, R | 1 |
| Shoptaw, S | 1 |
| Herrera-Guzmán, I | 1 |
| Gudayol-Ferré, E | 1 |
| Lira-Mandujano, J | 1 |
| Herrera-Abarca, J | 1 |
| Herrera-Guzmán, D | 1 |
| Montoya-Pérez, K | 1 |
| Guardia-Olmos, J | 1 |
| Hughes, S | 1 |
| Barnett, S | 1 |
| Sosnouski, P | 1 |
| Kirksey, DF | 1 |
| Zisook, S | 1 |
| Downs, NS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Relative Efficacy of Aerobic Exercise in the Treatment of Adults With Attention Deficit Hyperactivity Disorder (ADHD) Versus Medication Only and the Combination of the Two: A Pilot Study[NCT02788851] | 70 participants (Anticipated) | Interventional | 2016-04-30 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for bupropion and Cognition Disorders
| Article | Year |
|---|---|
Management of methamphetamine abuse and dependence.
Topics: Baclofen; Benzhydryl Compounds; Brain; Bupropion; Cognition Disorders; Cognitive Behavioral Therapy; | 2006 |
3 trials available for bupropion and Cognition Disorders
| Article | Year |
|---|---|
Effects of bupropion on cognitive performance during initial tobacco abstinence.
Topics: Adult; Antidepressive Agents, Second-Generation; Attention; Bupropion; Cognition Disorders; Cross-Ov | 2013 |
Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion.
Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Cognition Disorders; Depressive Disorder | 2015 |
Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
Topics: Adult; Attention; Bupropion; Cognition Disorders; Delayed-Action Preparations; Dopamine Uptake Inhib | 2005 |
4 other studies available for bupropion and Cognition Disorders
| Article | Year |
|---|---|
ADHD and pregnancy.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; | 2014 |
Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Brief Psychiatric Rating Scale; Bupropion; Cognitio | 2008 |
A clinical trial of bupropion in the treatment of depressed outpatients.
Topics: Adult; Aged; Ambulatory Care; Bupropion; Cognition Disorders; Depression; Drug Evaluation; Drug Inte | 1984 |
Diagnosis and treatment of depression in late life.
Topics: Adult; Age Factors; Aged; Antidepressive Agents; Bupropion; Cognition Disorders; Combined Modality T | 1998 |